IFNG and myeloid sarcoma: Our study demonstrated that transplantation of IFN-γ-hUCMSCs could reduce inflammation in EAE mice via the Foxp3/ROR-γt/STAT3 signaling pathway, which highlights the therapeutic effects of IFN-γ-hUCMSCs in patients with MS.